Futura Medical (LON:FUM) Shares Up 12% – Still a Buy?

Futura Medical plc (LON:FUM) was up 12% during mid-day trading on Thursday. The stock traded as high as GBX 0.28 and last traded at GBX 0.28. Approximately 14,402,046 shares traded hands during trading, an increase of 28% from the average session volume of 11,278,960 shares. The stock had previously closed at GBX 0.25.

Futura Medical Price Performance

The company has a market capitalization of £4.15 million, a P/E ratio of -0.35 and a beta of 0.02. The stock’s 50 day moving average is GBX 0.21 and its 200-day moving average is GBX 0.68.

Futura Medical (LON:FUM) last posted its quarterly earnings data on Tuesday, September 1st. The company reported GBX (0.20) earnings per share for the quarter. Futura Medical had a negative net margin of 158.21% and a negative return on equity of 152.42%. On average, equities research analysts anticipate that Futura Medical plc will post 2.85 EPS for the current year.

Futura Medical Company Profile

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products. Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.